ALNY vs. RTX
Compare and contrast key facts about Alnylam Pharmaceuticals, Inc. (ALNY) and Raytheon Technologies Corporation (RTX).
Performance
ALNY vs. RTX - Performance Comparison
Loading graphics...
ALNY vs. RTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ALNY Alnylam Pharmaceuticals, Inc. | -16.79% | 68.99% | 22.94% | -19.46% | 40.14% | 30.48% | 12.85% | 57.96% | -42.61% | 239.34% |
RTX Raytheon Technologies Corporation | 5.53% | 61.44% | 40.76% | -14.44% | 20.01% | 23.27% | -7.70% | 43.82% | -14.66% | 19.13% |
Fundamentals
ALNY:
$45.09B
RTX:
$262.67B
ALNY:
$2.33
RTX:
$4.96
ALNY:
141.77
RTX:
38.88
ALNY:
11.98
RTX:
2.95
ALNY:
57.14
RTX:
4.03
ALNY:
$3.71B
RTX:
$88.60B
ALNY:
$3.04B
RTX:
$17.79B
ALNY:
$472.68M
RTX:
$13.63B
Returns By Period
In the year-to-date period, ALNY achieves a -16.79% return, which is significantly lower than RTX's 5.53% return. Over the past 10 years, ALNY has outperformed RTX with an annualized return of 17.71%, while RTX has yielded a comparatively lower 16.43% annualized return.
ALNY
- 1D
- 4.68%
- 1M
- -0.62%
- YTD
- -16.79%
- 6M
- -27.44%
- 1Y
- 22.54%
- 3Y*
- 18.21%
- 5Y*
- 18.47%
- 10Y*
- 17.71%
RTX
- 1D
- 3.07%
- 1M
- -4.80%
- YTD
- 5.53%
- 6M
- 16.12%
- 1Y
- 48.09%
- 3Y*
- 28.12%
- 5Y*
- 22.79%
- 10Y*
- 16.43%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ALNY vs. RTX — Risk / Return Rank
ALNY
RTX
ALNY vs. RTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Alnylam Pharmaceuticals, Inc. (ALNY) and Raytheon Technologies Corporation (RTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ALNY | RTX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.55 | 1.73 | -1.18 |
Sortino ratioReturn per unit of downside risk | 1.05 | 2.25 | -1.20 |
Omega ratioGain probability vs. loss probability | 1.14 | 1.35 | -0.21 |
Calmar ratioReturn relative to maximum drawdown | 0.62 | 3.36 | -2.74 |
Martin ratioReturn relative to average drawdown | 1.38 | 14.15 | -12.77 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| ALNY | RTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.55 | 1.73 | -1.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.38 | 0.97 | -0.59 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.33 | 0.60 | -0.27 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.34 | 0.44 | -0.11 |
Correlation
The correlation between ALNY and RTX is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
ALNY vs. RTX - Dividend Comparison
ALNY has not paid dividends to shareholders, while RTX's dividend yield for the trailing twelve months is around 1.41%.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ALNY Alnylam Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RTX Raytheon Technologies Corporation | 1.41% | 1.46% | 2.14% | 2.76% | 2.14% | 2.33% | 21.21% | 1.96% | 2.66% | 2.13% | 2.39% | 2.66% |
Drawdowns
ALNY vs. RTX - Drawdown Comparison
The maximum ALNY drawdown since its inception was -83.58%, which is greater than RTX's maximum drawdown of -55.14%. Use the drawdown chart below to compare losses from any high point for ALNY and RTX.
Loading graphics...
Drawdown Indicators
| ALNY | RTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -83.58% | -55.14% | -28.44% |
Max Drawdown (1Y)Largest decline over 1 year | -37.57% | -14.57% | -23.00% |
Max Drawdown (5Y)Largest decline over 5 years | -42.46% | -32.84% | -9.62% |
Max Drawdown (10Y)Largest decline over 10 years | -59.95% | -51.98% | -7.97% |
Current DrawdownCurrent decline from peak | -32.64% | -9.08% | -23.56% |
Average DrawdownAverage peak-to-trough decline | -30.53% | -13.03% | -17.50% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.81% | 3.46% | +13.35% |
Volatility
ALNY vs. RTX - Volatility Comparison
Alnylam Pharmaceuticals, Inc. (ALNY) has a higher volatility of 10.49% compared to Raytheon Technologies Corporation (RTX) at 7.24%. This indicates that ALNY's price experiences larger fluctuations and is considered to be riskier than RTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| ALNY | RTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.49% | 7.24% | +3.25% |
Volatility (6M)Calculated over the trailing 6-month period | 25.91% | 18.20% | +7.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 41.46% | 27.98% | +13.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 48.70% | 23.54% | +25.16% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 54.25% | 27.57% | +26.68% |
Financials
ALNY vs. RTX - Financials Comparison
This section allows you to compare key financial metrics between Alnylam Pharmaceuticals, Inc. and Raytheon Technologies Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ALNY vs. RTX - Profitability Comparison
ALNY - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Alnylam Pharmaceuticals, Inc. reported a gross profit of 834.02M and revenue of 1.10B. Therefore, the gross margin over that period was 76.0%.
RTX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Raytheon Technologies Corporation reported a gross profit of 4.72B and revenue of 24.24B. Therefore, the gross margin over that period was 19.5%.
ALNY - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Alnylam Pharmaceuticals, Inc. reported an operating income of 131.72M and revenue of 1.10B, resulting in an operating margin of 12.0%.
RTX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Raytheon Technologies Corporation reported an operating income of 2.31B and revenue of 24.24B, resulting in an operating margin of 9.5%.
ALNY - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Alnylam Pharmaceuticals, Inc. reported a net income of 186.42M and revenue of 1.10B, resulting in a net margin of 17.0%.
RTX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Raytheon Technologies Corporation reported a net income of 1.62B and revenue of 24.24B, resulting in a net margin of 6.7%.